Arman Hasani

460 total citations
16 papers, 332 citations indexed

About

Arman Hasani is a scholar working on Pulmonary and Respiratory Medicine, Oncology and General Health Professions. According to data from OpenAlex, Arman Hasani has authored 16 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in General Health Professions. Recurrent topics in Arman Hasani's work include Occupational and environmental lung diseases (10 papers), Pleural and Pulmonary Diseases (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Arman Hasani is often cited by papers focused on Occupational and environmental lung diseases (10 papers), Pleural and Pulmonary Diseases (8 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Arman Hasani collaborates with scholars based in Australia, Canada and United States. Arman Hasani's co-authors include Anna K. Nowak, Michael Millward, Arthur W. Musk, Amanda Segal, Natasha B. Leighl, Roslyn J. Francis, Michael Byrne, Jenette Creaney, John M. Alvarez and Sean Bydder and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Journal of Thoracic Oncology.

In The Last Decade

Arman Hasani

13 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arman Hasani Australia 9 197 83 58 53 32 16 332
Abhinav Sidana United States 10 170 0.9× 75 0.9× 33 0.6× 50 0.9× 48 1.5× 28 269
Diego Enrico Argentina 8 64 0.3× 136 1.6× 45 0.8× 29 0.5× 42 1.3× 29 215
Bamidele Adesunloye United States 8 177 0.9× 178 2.1× 29 0.5× 17 0.3× 42 1.3× 19 339
Elena Collovà Italy 8 140 0.7× 155 1.9× 44 0.8× 9 0.2× 45 1.4× 23 352
Nancy N. Chang United States 8 155 0.8× 183 2.2× 162 2.8× 30 0.6× 54 1.7× 37 353
Christina Große-Thie Germany 10 60 0.3× 149 1.8× 35 0.6× 19 0.4× 53 1.7× 23 251
Grant Creaney United Kingdom 3 84 0.4× 107 1.3× 20 0.3× 40 0.8× 72 2.3× 3 354
Joseph C. Taylor United States 9 87 0.4× 86 1.0× 15 0.3× 17 0.3× 59 1.8× 12 303
Randa Loutfi United States 7 58 0.3× 162 2.0× 19 0.3× 67 1.3× 32 1.0× 10 272
Amy L. Cummings United States 11 117 0.6× 188 2.3× 54 0.9× 15 0.3× 52 1.6× 34 293

Countries citing papers authored by Arman Hasani

Since Specialization
Citations

This map shows the geographic impact of Arman Hasani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arman Hasani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arman Hasani more than expected).

Fields of papers citing papers by Arman Hasani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arman Hasani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arman Hasani. The network helps show where Arman Hasani may publish in the future.

Co-authorship network of co-authors of Arman Hasani

This figure shows the co-authorship network connecting the top 25 collaborators of Arman Hasani. A scholar is included among the top collaborators of Arman Hasani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arman Hasani. Arman Hasani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cook, Alistair, Alison M. McDonnell, Michael Millward, et al.. (2021). A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers. Expert Review of Anticancer Therapy. 21(5). 465–474.
2.
Norman, Richard, Matthew Anstey, Arman Hasani, Ian Li, & Suzanne Robinson. (2020). What Matters to Potential Patients in Chemotherapy Service Delivery? A Discrete Choice Experiment. Applied Health Economics and Health Policy. 18(4). 589–596. 3 indexed citations
3.
McMullen, Michelle, Peter K. H. Lau, Scott N. Taylor, et al.. (2017). Factors associated with psychological distress amongst outpatient chemotherapy patients: An analysis of depression, anxiety and stress using the DASS-21. Applied Nursing Research. 40. 45–50. 32 indexed citations
4.
Nowak, Anna K., Alistair Cook, Alison M. McDonnell, et al.. (2015). A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma. Annals of Oncology. 26(12). 2483–2490. 75 indexed citations
5.
Lau, Peter K. H., et al.. (2014). Patients Prefer Chemotherapy on the Same Day As Their Medical Oncology Outpatient Appointment. Journal of Oncology Practice. 10(6). e380–e384. 11 indexed citations
6.
Nowak, Anna K., Michael Millward, Jenette Creaney, et al.. (2012). A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 7(9). 1449–1456. 73 indexed citations
7.
Labby, Zacariah E., Samuel G. Armato, Hedy L. Kindler, et al.. (2012). Optimization of Response Classification Criteria for Patients with Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 7(11). 1728–1734. 16 indexed citations
8.
Hasani, Arman & Natasha B. Leighl. (2011). Classification and Toxicities of Vascular Disrupting Agents. Clinical Lung Cancer. 12(1). 18–25. 30 indexed citations
9.
Hasani, Arman, et al.. (2011). Systemic therapy usage and outcomes for patients diagnosed with malignant pleural mesothelioma (MPM) between 2005 and 2010 in Ontario, Canada.. Journal of Clinical Oncology. 29(15_suppl). 7085–7085. 1 indexed citations
10.
Hasani, Arman & Natasha B. Leighl. (2010). Targeting Vascular Endothelial Growth Factor in Lung Cancer. Journal of Thoracic Oncology. 5(12). S484–S486. 2 indexed citations
11.
Hasani, Arman, Kynan Feeney, Anna K. Nowak, & Michael Millward. (2010). Audit of patients with mesothelioma treated with pemetrexed in a single institution in Western Australia. Asia-Pacific Journal of Clinical Oncology. 6(4). 350–356.
12.
Nowak, Anna K., Michael Millward, Roslyn J. Francis, et al.. (2010). Final results of a phase II study of sunitinib as second-line therapy in malignant pleural mesothelioma (MPM).. Journal of Clinical Oncology. 28(15_suppl). 7036–7036. 14 indexed citations
13.
14.
Hasani, Arman, John M. Alvarez, Jenny Ma Wyatt, et al.. (2009). Outcome for Patients with Malignant Pleural Mesothelioma Referred for Trimodality Therapy in Western Australia. Journal of Thoracic Oncology. 4(8). 1010–1016. 51 indexed citations
15.
Hasani, Arman & Anna K. Nowak. (2009). Current Management of Malignant Pleural Mesothelioma. UWA Profiles and Research Repository (University of Western Australia). 1(1). 1–11. 1 indexed citations
16.
Hasani, Arman, et al.. (2005). The effective parameters on the patient satisfaction level of the referral patients to the out-patient physiotherapy clinics of the Semnan medical sciences university (second half of the year 2001). Koomesh Journal. 6(2). 167–174. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abhinav Sidana Breakdown of academic impact, for papers by Diego Enrico Breakdown of academic impact, for papers by Bamidele Adesunloye Breakdown of academic impact, for papers by Elena Collovà Breakdown of academic impact, for papers by Nancy N. Chang Breakdown of academic impact, for papers by Christina Große-Thie Breakdown of academic impact, for papers by Grant Creaney Breakdown of academic impact, for papers by Joseph C. Taylor Breakdown of academic impact, for papers by Randa Loutfi Breakdown of academic impact, for papers by Amy L. Cummings
Rankless by CCL
2026